UK BIO-TRAC (IRAS Ref. 227580) Study

About the Study:

This survey is part of the UK BIO-TRAC study and aims to assess the extent to which biological medicinal products (‘biologics’) are traceable within the hospital setting and how this may facilitate the reporting of an adverse drug reaction (ADR). The survey focuses on recording of brand name and batch number during the processes of prescribing, dispensing and administration of biologics in the hospital setting. The study is a collaborative project between DSRU and colleagues at Escher (https://www.lygature.org/escher) in the Netherlands.